Core Cap Advisors, LLC Standard Biotools Inc. Transaction History
Core Cap Advisors, LLC
- $2.12 Billion
- Q4 2024
A detailed history of Core Cap Advisors, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 151 shares of LAB stock, worth $200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151Holding current value
$200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
270MCall Options Held
27.2KPut Options Held
14.1K-
Casdin Capital, LLC New York, NY71.3MShares$94.8 Million10.73% of portfolio
-
Viking Global Investors LP58.7MShares$78 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$22.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$22.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $105M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...